This announcement is a separate document:
心通醫療-B:2024年上半年盈利預告 — 淨虧損大幅減少約63%至72%
CARDIOFLOW-B: PROFIT FORECAST FOR THE FIRST HALF OF 2024 -SIGNIFICANT REDUCTION IN NET LOSS OFAPPROXIMATELY 63% TO 72%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.